Drug Delivery Systems Market Trends

  • Report ID: 4460
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Drug Delivery Systems Market Growth Drivers and Challenges:

Growth Drivers

  • Technological Advancement and Innovations in Drug Delivery Systems- The rising development in technology has always favored market growth such as microneedle arrays are a new technology for delivering medications through the skin. In these arrays, several microscopic needles, each thinner than a strand of hair, are coated or filled with medicine. Therefore, technological advancement in drug delivery systems is anticipated to boost the market's growth in the upcoming years. Such as, Medtronic announced the release of Efficio, an advanced cloud-based data management technology application for use with SynchroMed II intramedullary drug delivery system in January 2020.

  • Rapid COVID-19 Vaccination Drive all over the World- There has been a rising demand for syringes owing to increasing COVID-19 vaccinations across the globe. Moreover, it has boosted the production of injectable drug delivery, and it is projected to drive the market's growth. According to the reported data, globally, 3.87 million vaccinations are done every day, and 12.69 billion doses have been given worldwide.

  • Growth of Digital Drug Delivery- The rising popularity and importance of digital drug delivery among companies is expected to increase the growth of the global drug delivery systems market. Nearly 60% of people working at a company size of 5000 believe that digital drug delivery technology is crucial.

Challenges

  • Strict Rules and Regulations Set by the Government - The government has imposed strict mandates to be followed while checking the product in order to ensure the efficacy and safety of the product. These stringent rules and regulations might limit the production of a new product or any other development of an old product. Therefore, the factor is likely to hamper the market growth.

  • Negative Impact and Data Security Risk Associated with Drug Delivery System

  • Customer Trust is Compromised Owing to the Invasive Nature of Drug Delivery

Base Year

2025

Forecast Period

2026-2035

CAGR

6.1%

Base Year Market Size (2025)

USD 48.66 billion

Forecast Year Market Size (2035)

USD 87.97 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of drug delivery systems is evaluated at USD 51.33 billion.

The global drug delivery systems market size was worth over USD 48.66 billion in 2025 and is poised to grow at a CAGR of around 6.1%, reaching USD 87.97 billion revenue by 2035.

The North America drug delivery systems market is predicted to capture 35% share by 2035, fueled by the high number of hospitalizations and the region’s efforts to improve drug delivery systems.

Key players in the market include BD (Becton, Dickinson, and Company), Gerreshelmer AG, Baxter, Nemara, Kindeva Drug Delivery, West Pharmaceutical Services Inc., Ypsomed, Medtronic Inc., E3D Elcam Drug Delivery Devices, Astra Zeneca, Merck KGaA.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos